Study of frog sartorius muscle acetylcholine receptor using the irreversible inhibitor TDF.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001665:Binding Sites; D001896:Boron Compounds / Q000494:pharmacology; D002217:Carbachol / Q000037:antagonists & inhibitors / Q000494:pharmacology; D003714:Denervation; D003979:Diazonium Compounds / Q000494:pharmacology*; D005461:Fluorine / Q000494:pharmacology; D007700:Kinetics; D008024:Ligands; D008564:Membrane Potentials / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009388:Neostigmine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D011950:Receptors, Cholinergic / Q000187:drug effects; D011955:Receptors, Drug / Q000187:drug effects*
D001896:Boron Compounds; D003979:Diazonium Compounds; D008024:Ligands; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D011950:Receptors, Cholinergic; D011955:Receptors, Drug; D005461:Fluorine; D009388:Neostigmine; D009538:Nicotine; D002217:Carbachol; D000109:Acetylcholine; D011188:Potassium